Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Post-Cesarean Nausea and Shivering
NCT03370562Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative shivering and postoperative nausea and vomiting (PONV) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Shivering measured by Visual analogue score at 60 minutes and Postoperative nausea and vomiting measured by Visual analogue score at 60 minutes. Started Feb 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative shiveringpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03370562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370562.